Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05647746Not ApplicableCompleted

Comparative Assessment of Compumedics Somfit Sleep Monitoring Device

Role: lead

NCT04326127Completed

Evaluation of Compumedics "Somfit" Device

Role: lead

NCT04324385Completed

Accuracy of Pulse Oximeters With Profound Hypoxia

Role: lead

NCT01210261Not ApplicableCompleted

New Versus Existing Auto-titrating CPAP Device to Treat Obstructive Sleep Apnea in Adults

Role: lead

All 4 trials loaded